Evidence map›Paper›PMID 38113026›Full record

ArticlePhotochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology2024

Optimal effective concentration combinations (OPECCs) for binary application of membrane-targeting antiseptics and TMPyP-mediated antimicrobial photodynamic therapy.

Tim Maisch, Konstantin J Scholz, Eva-Maria Forster, Verena Wenzl, David L Auer, Fabian Cieplik, Karl-Anton Hiller

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Tim MaischDepartment of Dermatology, University Hospital Regensburg, 93053, Regensburg, Germany. tim.maisch@ukr.de.ORCID http://orcid.org/0000-0002-1197-2628
Konstantin J ScholzDepartment of Conservative Dentistry and Periodontology, University Hospital Regensburg, 93053, Regensburg, Germany.ORCID http://orcid.org/0000-0003-4450-4238
Eva-Maria ForsterDepartment of Dermatology, University Hospital Regensburg, 93053, Regensburg, Germany.
Verena WenzlDepartment of Dermatology, University Hospital Regensburg, 93053, Regensburg, Germany.
David L AuerDepartment of Conservative Dentistry and Periodontology, University Hospital Regensburg, 93053, Regensburg, Germany.ORCID http://orcid.org/0000-0001-7077-6259
Fabian CieplikDepartment of Conservative Dentistry and Periodontology, University Hospital Regensburg, 93053, Regensburg, Germany.ORCID http://orcid.org/0000-0002-1750-7380
Karl-Anton HillerDepartment of Conservative Dentistry and Periodontology, University Hospital Regensburg, 93053, Regensburg, Germany.ORCID http://orcid.org/0000-0002-4726-9555
University Hospital Regensburg · DE

Funding

Deutsche Forschungsgemeinschaft CI 263/3-1
6 · The paper itself

Abstract

The widespread occurrence of multi-resistant bacteria is a health problem of global dimension. Infections caused by multi-resistant pathogens are difficult to treat and often associated with high mortality. Therefore, new treatment strategies are of interest, such as the use of differently acting antibacterial concepts. One of these new concepts is the use of antiseptics in combination with the antibacterial photodynamic therapy (aPDT). Currently, no method has yet been established as a standard procedure for investigating combined effects and evaluating them in a generally valid and unambiguous manner. The focus of this study was on how cationic antiseptics benzalkonium chloride (BAC) and chlorhexidine digluconate (CHX) behave in a combined application with aPDT using the photosensitizer TMPyP. For this purpose, BAC and CHX were applied in combination with the aPDT using TMPyP in non-lethal concentrations to the three bacteria Escherichia coli, Staphylococcus aureus, and Enterococcus faecalis. The results of the combination experiments with sublethal concentrations of BAC or CHX with the aPDT showed that the binary application had a lethal effect. Irrespective of the bacteria, the reduction in concentrations in OPECC, compared to individual concentrations, was more than 50% for TMPyP, 23-40% for BAC, and 18-43% for CHX. Furthermore, the optimal effective concentration combinations (OPECCs) could be determined. The latter showed that the combined application allowed the reduction of both concentrations compared to the single application.

Indexed as

Anti-Infective Agents, LocalPhotochemotherapyAnti-Bacterial AgentsBacteriaBiofilmsEscherichia coliPhotosensitizing AgentsAnti-Bacterial AgentsAnti-Infective Agents, LocalPhotosensitizing AgentsAntimicrobial photodynamic therapyAntisepticsaPDTBinaryOPECCSynergy

Identifiers

PMID38113026
OpenAlexW4389938722

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.